Investor · 1 deal
Every published round Pacific Chan took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Navi Medical Technologies | Unnamed stage | 4 Aug 2026 | $6.8m | Participant | Startup Daily (4 Aug 2026), bushletter.com, SmartCompany, raising.fi, PR Newswire, meditechtoday.com, navitechnologies.com, Startup Daily (28 Jul 2026) |
Companies Pacific Chan has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Navi Medical Technologies | Developer of Neonav, a vascular device to help clinicians insert catheters into veins of … | 4 Aug 2026 | 1 | 0 |
Fund closes reported for Pacific Chan, as distinct from the investments it has made.
Companies Pacific Chan has backed that another company then bought. An exit for the holding, not a deal Pacific Chan did.
| Name | Role | Sources |
|---|---|---|
| Paul Carrett | CIO | Wholesale Investor |
Stories naming Pacific Chan. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup of eight Australian and New Zealand startups whose late-July funding totals $102 million across space capsules, medical devices, livestock breath analysis, sports analytics and AI crop forecasting.
Melbourne paediatric device maker Navi Medical Technologies has banked $6.8 million, led by KP Rx, to take its Neonav catheter tool into the US market following regulatory clearance.
Also navitechnologies.com·meditechtoday.com·PR Newswire·SmartCompany·raising.fi·Startup Daily·bushletter.com
Wholesale Investor profiles Altive's Unicorns Fund, a closed-end private equity vehicle backed by Alibaba and Pacific Century Group, opening pre-IPO technology opportunities to Australian investors, with a team drawn from Goldman Sachs and Macquarie.